TLRY Stock Overview A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Tilray Brands, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Tilray Brands Historical stock prices Current Share Price US$1.90 52 Week High US$4.00 52 Week Low US$1.65 Beta 2.06 1 Month Change 0.53% 3 Month Change -16.67% 1 Year Change -36.03% 3 Year Change -79.05% 5 Year Change n/a Change since IPO -90.19%
Recent News & Updates
Tilray Brands, Inc. Explores the Latest Cannabis Beverages from Solei, Mollo, and XMG Dec 31
Tilray Brands, Inc. to Report Q2, 2025 Results on Jan 09, 2025 Dec 19
Redecan Cannabis, Brand Under Tilray Brands, Inc, Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-Roll Line for the Holidays Dec 18
Tilray Brands, Inc. Appoints Steven M. Cohen as Class III Board Member Dec 14
Tilray Brands, Inc. Launches New Product Lineup Dec 13
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages Dec 12 See more updates
Tilray Brands, Inc. Explores the Latest Cannabis Beverages from Solei, Mollo, and XMG Dec 31
Tilray Brands, Inc. to Report Q2, 2025 Results on Jan 09, 2025 Dec 19
Redecan Cannabis, Brand Under Tilray Brands, Inc, Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-Roll Line for the Holidays Dec 18
Tilray Brands, Inc. Appoints Steven M. Cohen as Class III Board Member Dec 14
Tilray Brands, Inc. Launches New Product Lineup Dec 13
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages Dec 12
New minor risk - Profitability Nov 18
No longer forecast to breakeven Nov 18
Tilray Brands, Inc. Announces Fall Craft Beer Lineup Oct 16
First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Oct 10
Tilray Brands Launches Charlotte's Web CBD Gummies in Canada Oct 07
Tilray Brands, Inc. to Report Q1, 2025 Results on Oct 10, 2024 Oct 01
Tilray Brands, Inc., Annual General Meeting, Nov 21, 2024 Sep 19
No longer forecast to breakeven Sep 11
New minor risk - Shareholder dilution Sep 08 Tilray Brands, Inc. (NasdaqGS:TLRY) completed the acquisition of Terrapin Beer Co and Atwater Brewing Co. and Hop Valley Brewing Co and Revolver Brewing, LLC from Molson Coors Beverage Company (NYSE:TAP). Sep 04
Entrepreneurial Equity Partners, L.P. acquired Truss Beverage Co. from Tilray Brands, Inc. (NasdaqGS:TLRY). Aug 17
Tilray Brands, Inc. Announces the Expansion of its Solei Cannabis Product Lineup Aug 15 Jul 31
Full year 2024 earnings: EPS misses analyst expectations Jul 30
Tilray Brands, Inc. to Report Q4, 2024 Results on Jul 29, 2024 Jul 16
Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape Innovations Jul 10
Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews Jun 27
Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan Cannabis Jun 08
Insufficient new directors Jun 02
Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One Vape May 31
Forecast to breakeven in 2027 May 31
Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’ May 24
Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million. May 19 Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million. May 18
Tilray Brands, Inc Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage May 03
Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen May 02
Tilray Brands, Inc. Introduces New Signature 'Bud Squad' Products Apr 24
No longer forecast to breakeven Apr 10
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Apr 09
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use Apr 03
Tilray Brands, Inc. to Report Q3, 2024 Results on Apr 09, 2024 Mar 29
Tilray Brands, Inc. Announces Redecan Cannabis Launches New Spring Lineup Mar 22
Tilray Brands, Inc. Introduces New Naturally Flavoured CBG Infused Cannabis Beverages Mar 14
Manitoba Harvest Hemp Foods Introduces Protein-Rich Breakfast Staples with New Superseed Instant Oatmeal Mar 08
Tilray Brands, Inc. Announces the Latest Craft Flower Releases by Premium Cannabis Brand, Broken Coast Mar 06
Tilray Brands, Inc. Debuts Two New Ready-To-Drink Cold Brew Tea Beverages by Its Premium Cannabis Wellness Brand, Solei Feb 23
No longer forecast to breakeven Feb 15
Tilray Brands, Inc. Shares its Cannabis Lineup for Sports Fans Feb 07
Forecast to breakeven in 2026 Feb 01
Tilray Brands Unveils Craft Beer Locks for the Big Game Feb 01
Tilray Brands, Inc. Unveils the Latest Additions to the Diamond Collection from Premium Cannabis Brand, RIFF Jan 23
No longer forecast to breakeven Jan 10
Second quarter 2024 earnings released: US$0.07 loss per share (vs US$0.11 loss in 2Q 2023) Jan 10 Tilray Brands, Inc. to Report Q2, 2024 Results on Jan 09, 2024
Tilray Brands, Inc. Through Its Wholly-Owned Licensed Subsidiaries, Aphria Inc, and Hexo Operations Inc., and Truss Beverages Company Limited Unveil Canadian Cannabis Lineup for the Holidays Dec 06
Tilray Brands, Inc. Announces the Launch of Redecan’S New Redees ‘Hemp’d’ Pre-Rolls Nov 23
Tilray Brands, Inc. Expands Cannabis Beverage Portfolio with New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands Nov 17
Good Supply Cannabis Launches 'Get Blitzen’d' Holiday Campaign and New Limited-Edition Products Across Canada Nov 10
Tilray Brands, Inc. (NasdaqGS:TLRY) acquired 1000652011 Ontario Inc. from MediPharm Labs Corp. (TSX:LABS) for CAD 8.5 million. Oct 06
New minor risk - Profitability Oct 05
No longer forecast to breakeven Oct 05
First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Oct 05
Tilray Brands, Inc., Annual General Meeting, Nov 21, 2023 Sep 28
New minor risk - Shareholder dilution Sep 26
Tilray Brands, Inc. to Report Q1, 2024 Results on Oct 04, 2023 Sep 22
Now 22% undervalued Sep 07
Tilray Brands, Inc. Debuts Two New Ready-To-Drink Carbonated Beverages by Its Premium Cannabis Wellness Brand, Solei Aug 25
Tilray Brands, Inc. (NasdaqGS:TLRY) acquired remaining 57.5% stake in Truss Beverage Co.™ from Molson Coors Canada Inc. (TSX:TPX.B). Aug 19
Tilray Brands, Inc. Announces the Launch of the New Juiced Infused Pre-Rolls by Its Canadian Cannabis Brand, Good Supply Aug 18
New minor risk - Share price stability Aug 03
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Jul 26 Tilray Brands, Inc. to Report Q4, 2023 Results on Jul 26, 2023
Tilray Brands, Inc. (NasdaqGS:TLRY) completed the acquisition of HEXO Corp. (TSX:HEXO). Jun 23
Tilray Brands Expands Beer Portfolio and Launches Good Supply Light Beer Jun 15
Forecast to breakeven in 2026 Jun 01
Tilray Brands, Inc. Debuts Premium CBD, CBN and THC Infused Tea Collection May 12
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Apr 12
Tilray Brands, Inc. Launches New Product Lineup Feb 15
Breckenridge Distillery Launches Limited-Edition Sexy Motor Oil Whiskey for Valentine’s Day Feb 09
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Jan 09
Tilray Brands, Inc. to Report Q2, 2023 Results on Jan 09, 2023 Dec 21
Tilray Brands, Inc. Announces Launch of A New Limited Edition, Premium Craft Flower Series by Lifestyle Brand, RIFF Dec 17
Good Supply Cannabis Brand Launches ‘Peppermint Phatty’ Dec 07
Tilray Brands, Inc., Annual General Meeting, Dec 20, 2022 Dec 02
High number of new directors Nov 16
Tilray Brands, Inc. Announces the Expansion of Their Canaca Cannabis Brand Portfolio Nov 11
Tilray Brands, Inc. (NasdaqGS:TLRY) acquired Montauk Brewing Co. Nov 08
Tilray Brands, Inc. Reveals New Fall Flower Launches and Expands Distribution of Bestselling High-Potency Products Oct 29
First quarter 2023 earnings: EPS and revenues miss analyst expectations Oct 08
Tilray Brands, Inc. Medical Relaunches Cannabis Oral Solution Across Ireland Oct 06
Tilray Brands, Inc., Annual General Meeting, Nov 22, 2022 Oct 04 Tilray Brands, Inc. to Report Q1, 2023 Results on Oct 07, 2022
Riff Cannabis Brand Launches Drumsticks Sep 16
Tilray Brands, Inc. Announces Expansion of Good Supply’s Cannabis Portfolio Sep 02 Shareholder Returns TLRY CA Pharmaceuticals CA Market 7D -5.9% -1.1% -0.5% 1Y -36.0% -32.0% 14.9%
See full shareholder returns
Return vs Market: TLRY underperformed the Canadian Market which returned 14.9% over the past year.
Price Volatility Is TLRY's price volatile compared to industry and market? TLRY volatility TLRY Average Weekly Movement 8.2% Pharmaceuticals Industry Average Movement 12.1% Market Average Movement 8.1% 10% most volatile stocks in CA Market 17.2% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: TLRY has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: TLRY's weekly volatility (8%) has been stable over the past year.
About the Company Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products.
Show more Tilray Brands, Inc. Fundamentals Summary How do Tilray Brands's earnings and revenue compare to its market cap? TLRY fundamental statistics Market cap CA$1.77b Earnings (TTM ) -CA$306.23m Revenue (TTM ) CA$1.17b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) TLRY income statement (TTM ) Revenue US$812.04m Cost of Revenue US$565.88m Gross Profit US$246.16m Other Expenses US$458.78m Earnings -US$212.62m
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
Jan 09, 2025
Earnings per share (EPS) -0.24 Gross Margin 30.31% Net Profit Margin -26.18% Debt/Equity Ratio 9.2%
How did TLRY perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/31 22:52 End of Day Share Price 2024/12/31 00:00 Earnings 2024/08/31 Annual Earnings 2024/05/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Tilray Brands, Inc. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Aaron Grey Alliance Global Partners Frederico Yokota Choucair Gomes ATB Capital Markets Gaurav Jain Barclays
Show 28 more analysts 
